Cytosorbents's market cap is currently $59.81M. The company's EPS TTM is $0.03; its P/E ratio is ―; Cytosorbents is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
